The long term kinetics of the IgA response for infection + vaccination individuals after 6 months mirrored the infection-only group, suggesting that localized SARS-CoV-2 infection in the respiratory tract may be necessary for sustained SARS-CoV-2-specific IgA production and mucosal immunity [24]. Here, CD79A is linked to infection.